Synergistic effect of heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin and X-rays, but not carbon-ion beams, on lethality in human oral squamous cell carcinoma cells
- PMID: 22843619
- PMCID: PMC3393353
- DOI: 10.1093/jrr/rrs012
Synergistic effect of heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin and X-rays, but not carbon-ion beams, on lethality in human oral squamous cell carcinoma cells
Abstract
The purpose of this study is to clarify the effect of a heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin (17-AAG), in combination with X-rays or carbon-ion beams on cell killing in human oral squamous cell carcinoma LMF4 cells. Cell survival was measured by colony formation assay. Cell-cycle distribution was analyzed by flow cytometry. Expression of DNA repair-related proteins was investigated by western blotting. The results showed 17-AAG to have synergistic effects on cell lethality with X-rays, but not with carbon-ion beams. The 17-AAG decreased G(2)/M arrest induced by X-rays, but not by carbon-ion beams. Both X-ray and carbon-ion irradiation up-regulated expression of non-homologous end-joining-associated proteins, Ku70 and Ku80, but 17-AAG inhibited only X-ray-induced up-regulation of these proteins. These results show that 17-AAG with X-rays releases G(2)/M phase arrest; cells carrying misrepaired DNA damage then move on to the G(1) phase. We demonstrate, for the first time, that the radiosensitization effect of 17-AAG is not seen with carbon-ion beams because 17-AAG does not affect these changes.
Figures



Similar articles
-
P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines.Int J Oncol. 2006 Nov;29(5):1111-7. doi: 10.3892/ijo.29.5.1111. Int J Oncol. 2006. PMID: 17016641
-
The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.Oncol Rep. 2014 Feb;31(2):619-24. doi: 10.3892/or.2013.2899. Epub 2013 Dec 5. Oncol Rep. 2014. PMID: 24317439
-
Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G2/M cell cycle arrest and apoptosis.Cancer Chemother Pharmacol. 2009 Aug;64(3):433-43. doi: 10.1007/s00280-008-0888-2. Epub 2008 Dec 12. Cancer Chemother Pharmacol. 2009. PMID: 19082595 Free PMC article.
-
Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.Br J Cancer. 2009 Jan 27;100(2):334-43. doi: 10.1038/sj.bjc.6604855. Epub 2009 Jan 13. Br J Cancer. 2009. PMID: 19142186 Free PMC article.
-
Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.J Neurosurg. 2010 Jan;112(1):33-42. doi: 10.3171/2009.3.JNS081146. J Neurosurg. 2010. PMID: 19408974
Cited by
-
Anti-cancer effects of chemotherapeutic agent; 17-AAG, in combined with gold nanoparticles and irradiation in human colorectal cancer cells.Daru. 2019 Jun;27(1):111-119. doi: 10.1007/s40199-019-00251-w. Epub 2019 Mar 5. Daru. 2019. PMID: 30835081 Free PMC article.
-
PU-H71, a novel Hsp90 inhibitor, as a potential cancer-specific sensitizer to carbon-ion beam therapy.J Radiat Res. 2016 Sep;57(5):572-575. doi: 10.1093/jrr/rrw054. Epub 2016 May 29. J Radiat Res. 2016. PMID: 27242340 Free PMC article.
-
Translational Research to Improve the Efficacy of Carbon Ion Radiotherapy: Experience of Gunma University.Front Oncol. 2016 Jun 9;6:139. doi: 10.3389/fonc.2016.00139. eCollection 2016. Front Oncol. 2016. PMID: 27376029 Free PMC article. Review.
-
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond.Front Pharmacol. 2024 Nov 5;15:1475998. doi: 10.3389/fphar.2024.1475998. eCollection 2024. Front Pharmacol. 2024. PMID: 39564119 Free PMC article. Review.
-
Multiomic-Based Molecular Landscape of FaDu Xenograft Tumors in Mice after a Combinatorial Treatment with Radiation and an HSP90 Inhibitor Identifies Adaptation-Induced Targets of Resistance and Therapeutic Intervention.Mol Cancer Ther. 2024 Apr 2;23(4):577-588. doi: 10.1158/1535-7163.MCT-23-0796. Mol Cancer Ther. 2024. PMID: 38359816 Free PMC article.
References
-
- Takahashi A, Ohnishi K, Wang X. The dependence of p53 on the radiation enhancement of thermosensitivity at different LET. Int J Radiat Oncol Biol Phys. 2000;47:489–94. - PubMed
-
- Iwadate Y, Mizoe J, Osaka Y, et al. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. Int J Radiat Oncol Biol Phys. 2001;50:803–8. - PubMed
-
- Takahashi A, Matsumoto H, Yuki K, et al. High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status. Int J Radiat Oncol Biol Phys. 2004;60:591–7. - PubMed
-
- Ogata T, Teshima T, Inaoka M, et al. Carbon ion irradiation suppresses metastatic potential of human non-small cell lung cancer A549 cells through the phosphatidylinositol-3-kinase/Akt signaling pathway. J Radiat Res. 2011;52:374–9. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials